プロテオミクスの市場規模、シェア、動向分析レポート：製品・サービス別、技術別、用途別、地域別、セグメント予測、2024年～2030年

プロテオミクス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のプロテオミクス市場規模は2024年から2030年にかけて13.10%のCAGRを記録し、2030年には581億6,000万米ドルに達すると予測されています。

業界の成長を促す主な要因は、個別化医療に対する需要の高まり、プロテオミクス質量分析計やバイオチッププラットフォームを活用した診断のパイプラインの拡大、ゲノミクスに基づく発見です。さらに、医薬品開発におけるプロテオミクスの重要性に起因して、多くの製薬会社が独自のプロテオミクス部門を設立しており、これが世界の業界の拡大に拍車をかけています。例えば、2021年9月、Biognosys社は、臨床研究と創薬における次世代プロテオミクスの利用を促進するため、Evotec社との提携を発表しました。

世界中の研究者がSARS-CoV-2タンパク質の3D構造の解読に集中していることから、COVID-19の発生は業界に大きな影響を与えると予想されます。COVID-19に対する効果的な医薬品や生物学的製剤を開発するために、科学者たちはこれらのタンパク質の同定技術、構造、特性、相互作用の検討も試みています。ウイルスの新規で効率的な標的治療薬を見つけるためには、ウイルスタンパク質の構造とその特定の位置を理解する必要があります。したがって、COVID-19の医薬品開発需要が増加し、業界の成長が促進されます。また、特注薬に対するニーズの高まりによる研究開発費の増加、プロテオミクス・コンポーネントに関する技術開発も市場を牽引しています。

さらに、質量分析ベースのプロテオミクスの改良とバイオマーカー同定に関連する有利な機会から、プロテオミクスの魅力的な市場拡大の可能性が見込まれます。これにより、市場の成長が促進されます。主要な業界参加者による新しく改良されたプロテオミクス技術のイントロダクションは、業界の成長をさらに加速すると予測されています。例えば、ショットガンプロテオミクスに迅速なデータ取得を提供するために、Bruker Corp.は2017年9月にPASEF（Parallel Accumulation And Serial Fragmentation）質量分析用のtimsTOF Proシステムを発表しました。このシステムは独自のTrapped Ion Mobility Spectrometry（TIMS）技術を使用しています。さらに、プロテオミクス研究の進歩により、タンパク質バイオマーカーの検出、タンパク質バイオチップ＆ファーマコプロテオミクス、プロテオミクスに基づく分子診断が加速しており、これらはいずれも個別化医療の発展に大きく貢献しています。

プロテオミクス市場レポートハイライト

• 研究活動の活発化と、効率的な分析のために複雑な混合物からタンパク質を分離する需要の高まりにより、試薬・消耗品製品セグメントが2023年に最大のシェアを占めました。
• 臨床診断アプリケーション分野は、疾病の早期発見と疾病管理のための高度で専門的な検査の開発により、2023年に大きなシェアを占めました。
• スペクトロスコピー技術セグメントは、毒物学的反応プロファイリング、基礎分子生物学、バイオマーカー同定、医薬品ターゲットスクリーニングでの使用増加により、2023年に最大シェアを占めました。
• 北米は、個別化医薬品の需要増加、米国で事業を展開する大手企業の存在、高度に発達したヘルスケア研究の枠組み、研究開発への多額の支出により、2023年に世界の業界をリードしました。
• アジア太平洋は、標的疾患の有病率の上昇、高齢化人口の増加、プロテオミクス導入の増加などの要因から、予測期間中に最も高いCAGRで成長すると予想されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 プロテオミクス市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場見通し。
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• プロテオミクス市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 プロテオミクス市場：製品・サービス別推定・動向分析

• セグメントダッシュボード
• 世界のプロテオミクス市場：製品・サービス別変動分析
• 世界のプロテオミクス市場規模と動向分析、製品・サービス別、2018～2030年
• 機器
• 試薬・消耗品
• サービス

第5章 プロテオミクス市場：用途別推定・動向分析

• セグメントダッシュボード
• 世界のプロテオミクス市場：用途別変動分析
• 世界のプロテオミクス市場規模と動向分析、用途別、2018～2030年
• 創薬
• 臨床診断
• その他

第6章 プロテオミクス市場：技術別推定・動向分析

• セグメントダッシュボード
• 世界のプロテオミクス市場：技術別変動分析
• 世界のプロテオミクス市場規模と動向分析、技術別、2018～2030年
• 次世代シーケンシング
• マイクロアレイ機器
• X線結晶構造解析
• 分光測定
• クロマトグラフィー
• タンパク質分画システム
• 電気泳動
• 表面プラズマ共鳴（SPR）システム
• その他の技術

第7章 プロテオミクス市場：地域別推定・動向分析

• 地域別市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 市場規模、予測動向分析、2018年から2030年：
• 北米
  • 北米市場推計・予測2018～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 2018年から2030年までの欧州市場推計・予測
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • アジア太平洋市場推計・予測2018～2030年
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ラテンアメリカ市場推計・予測2018～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ市場推計・予測2018年から2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2023年
• 企業プロファイル/上場企業
  • Illumina Inc.
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Bruker Corporation
  • F. Hoffmann-La Roche Ltd.
  • Waters Corporation
  • Merck KGaA
  • Danaher
  • Standard BioTools Inc.

List of Tables

• Table 1 List of abbreviation
• Table 2 Global proteomics market, by region, 2018 - 2030 (USD Million)
• Table 3 Global proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 4 Global proteomics market, by application, 2018 - 2030 (USD Million)
• Table 5 Global proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 6 North America proteomics market, by country, 2018 - 2030 (USD Million)
• Table 7 North America proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 8 North America proteomics market, by application, 2018 - 2030 (USD Million)
• Table 9 North America proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 10 U.S. proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 11 U.S. proteomics market, by application, 2018 - 2030 (USD Million)
• Table 12 U.S. proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 13 Canada proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 14 Canada proteomics market, by application, 2018 - 2030 (USD Million)
• Table 15 Canada proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 16 Mexico proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 17 Mexico proteomics market, by application, 2018 - 2030 (USD Million)
• Table 18 Mexico proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 19 Europe proteomics market, by country, 2018 - 2030 (USD Million)
• Table 20 Europe proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 21 Europe proteomics market, by application, 2018 - 2030 (USD Million)
• Table 22 Europe proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 23 UK proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 24 UK proteomics market, by application, 2018 - 2030 (USD Million)
• Table 25 UK proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 26 Germany proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 27 Germany proteomics market, by application, 2018 - 2030 (USD Million)
• Table 28 Germany proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 29 France proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 30 France proteomics market, by application, 2018 - 2030 (USD Million)
• Table 31 France proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 32 Italy proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 33 Italy proteomics market, by application, 2018 - 2030 (USD Million)
• Table 34 Italy proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 35 Spain proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 36 Spain proteomics market, by application, 2018 - 2030 (USD Million)
• Table 37 Spain proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 38 Denmark proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 39 Denmark proteomics market, by application, 2018 - 2030 (USD Million)
• Table 40 Denmark proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 41 Sweden proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 42 Sweden proteomics market, by application, 2018 - 2030 (USD Million)
• Table 43 Sweden proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 44 Norway proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 45 Norway proteomics market, by application, 2018 - 2030 (USD Million)
• Table 46 Norway proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific proteomics market, by country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific proteomics market, by application, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 51 China proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 52 China proteomics market, by application, 2018 - 2030 (USD Million)
• Table 53 China proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 54 Japan proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 55 Japan proteomics market, by application, 2018 - 2030 (USD Million)
• Table 56 Japan proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 57 India proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 58 India proteomics market, by application, 2018 - 2030 (USD Million)
• Table 59 India proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 60 South Korea proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 61 South Korea proteomics market, by application, 2018 - 2030 (USD Million)
• Table 62 South Korea proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 63 Australia proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 64 Australia proteomics market, by application, 2018 - 2030 (USD Million)
• Table 65 Australia proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 66 Thailand proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 67 Thailand proteomics market, by application, 2018 - 2030 (USD Million)
• Table 68 Thailand proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 69 Latin America proteomics market, by country, 2018 - 2030 (USD Million)
• Table 70 Latin America proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 71 Latin America proteomics market, by application, 2018 - 2030 (USD Million)
• Table 72 Latin America proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 73 Brazil proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 74 Brazil proteomics market, by application, 2018 - 2030 (USD Million)
• Table 75 Brazil proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 76 Argentina proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 77 Argentina proteomics market, by application, 2018 - 2030 (USD Million)
• Table 78 Argentina proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 79 MEA proteomics market, by country, 2018 - 2030 (USD Million)
• Table 80 MEA proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 81 MEA proteomics market, by application, 2018 - 2030 (USD Million)
• Table 82 MEA proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 83 South Africa proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 84 South Africa proteomics market, by application, 2018 - 2030 (USD Million)
• Table 85 South Africa proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia proteomics market, by application, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 89 UAE proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 90 UAE proteomics market, by application, 2018 - 2030 (USD Million)
• Table 91 UAE proteomics market, by technology, 2018 - 2030 (USD Million)
• Table 92 Kuwait proteomics market, by product & service, 2018 - 2030 (USD Million)
• Table 93 Kuwait proteomics market, by application, 2018 - 2030 (USD Million)
• Table 94 Kuwait proteomics market, by technology, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 Proteomics market: Market outlook
• Fig. 5 Proteomics market: Segment outlook
• Fig. 6 Proteomics market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 Proteomics market driver impact
• Fig. 9 Proteomics market restraint impact
• Fig. 10 Proteomics market: Product & service outlook and key takeaways
• Fig. 11 Proteomics market: Product & service movement analysis
• Fig. 12 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 13 Reagents & consumables market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 14 Services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 15 Proteomics market: Application outlook and key takeaways
• Fig. 16 Proteomics market: Application movement analysis
• Fig. 17 Drug discovery market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 Clinical diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Proteomics market: Technology outlook and key takeaways
• Fig. 21 Proteomics market: Technology movement analysis
• Fig. 22 Next - generation sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Microarray instruments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 X - ray crystallography market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Chromatography market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Protein fractionation systems market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Electrophoresis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Surface plasma resonance (SPR) systems market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Other technologies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Global proteomics market: Regional outlook and key takeaways
• Fig. 32 Global proteomics market: Regional movement analysis
• Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Key country dynamics
• Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Key country dynamics
• Fig. 37 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Key country dynamics
• Fig. 39 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Key country dynamics
• Fig. 42 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Key country dynamics
• Fig. 44 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Key country dynamics
• Fig. 46 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Key country dynamics
• Fig. 48 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Key country dynamics
• Fig. 50 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Key country dynamics
• Fig. 52 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Key country dynamics
• Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Key country dynamics
• Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Key country dynamics
• Fig. 59 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Key country dynamics
• Fig. 61 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Key country dynamics
• Fig. 63 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Key country dynamics
• Fig. 65 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Key country dynamics
• Fig. 67 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Key country dynamics
• Fig. 69 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Key country dynamics
• Fig. 74 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Key country dynamics
• Fig. 77 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Key country dynamics
• Fig. 79 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics
• Fig. 81 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Proteomics Market Growth & Trends:

The global proteomics market size is expected to reach USD 58.16 billion by 2030, registering a CAGR of 13.10% from 2024 to 2030, according to a new report by Grand View Research, Inc. The major factors driving the industry growth are a rise in the demand for personalized medicine, an expansion of the pipeline of diagnostics utilizing proteomics mass spectrometry as well as biochip platforms, and discoveries based on genomics. Moreover, owing to the importance of proteomics in drug development, numerous pharmaceutical companies have established their own proteomic divisions, which are fueling the expansion of the global industry. For instance, in September 2021, Biognosys, announced the collaboration with Evotec, to promote the use of next-generation proteomics in clinical research and drug discovery.

The COVID-19 outbreak is expected to have a significant impact on the industry, as researchers across the world are concentrating on decoding 3D structures of SARS-CoV-2 proteins. To create effective medications and biological products against COVID-19, scientists are also attempting to examine the identification techniques, structures, characterization, and interactions of these proteins. The protein structure of virus proteins and their specific locations must be understood to find a novel, efficient target treatment medication for a virus. Therefore, it will increase the demand for drug development for COVID-19 and propel industry growth. The growing need for customized medications increased R&D spending, and technological developments related to proteomics components are also driving the market.

In addition, attractive market expansion potential for proteomics is anticipated to come from improvements in mass spectrometry-based proteomics and lucrative opportunities related to biomarker identification. Thereby, propelling the market growth. The introduction of new and improved proteomics techniques by major industry participants is projected to further accelerate the growth of the industry. For instance, to provide quick data acquisition for shotgun proteomics, Bruker Corp. introduced the timsTOF Pro system for Parallel Accumulation And Serial Fragmentation (PASEF) mass spectrometry in September 2017. This system uses proprietary Trapped Ion Mobility Spectrometry (TIMS) technology. Furthermore, proteomic research advancements have accelerated the detection of protein biomarkers, protein biochips & pharmacoproteomics, and proteomics-based molecular diagnostics, which have all made significant contributions to the development of personalized medicine.

Proteomics Market Report Highlights:

• The reagent & consumables product segment held the largest share in 2023 due to rising research activities and the growing demand for protein separation from complicated mixtures for efficient analysis
• The clinical diagnostics application segment held a larger share in 2023 due to the development of sophisticated & specialized tests for early disease detection and disease management
• The spectroscopy technology segment held the maximum share in 2023 owing to the increasing usage in toxicological response profiling, basic molecular biology, biomarker identification, and pharmaceutical target screening
• North America led the global industry in 2023 due to a rise in demand for personalized drugs, the existence of major players operating in the U.S. and a highly developed healthcare research framework, and substantial expenditure on R&D
• Asia Pacific is expected to grow at the highest CAGR over the projected period due to factors, such as the rising prevalence of target diseases, increasing aging population, and rising proteomics adoption

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Service Segment
  • 1.2.2. Application Segment
  • 1.2.3. Technology Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Proteomics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of chronic and infectious diseases
    • 3.2.1.2. Growing preference for personalized medicine
    • 3.2.1.3. Technological advancements in proteomics techniques
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of proteomics tools and instruments
• 3.3. Proteomics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Proteomics Market: Product & Service Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Proteomics Market Product & Service Movement Analysis
• 4.3. Global Proteomics Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Reagents & Consumables
  • 4.5.1. Reagents & consumables market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Services
  • 4.6.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Proteomics Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Proteomics Market Application Movement Analysis
• 5.3. Global Proteomics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Drug Discovery
  • 5.4.1. Drug discovery market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Clinical Diagnostics
  • 5.5.1. Clinical diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Proteomics Market: Technology Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Proteomics Market Technology Movement Analysis
• 6.3. Global Proteomics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
• 6.4. Next-generation Sequencing
  • 6.4.1. Next-generation sequencing market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Microarray Instruments
  • 6.5.1. Microarray instruments market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. X-ray Crystallography
  • 6.6.1. X-ray crystallography market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Spectrometry
  • 6.7.1. Spectrometry market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Chromatography
  • 6.8.1. Chromatography market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. Protein Fractionation Systems
  • 6.9.1. Protein fractionation systems market estimates and forecasts 2018 to 2030 (USD Million)
• 6.10. Electrophoresis
  • 6.10.1. Electrophoresis market estimates and forecasts 2018 to 2030 (USD Million)
• 6.11. Surface Plasma Resonance (SPR) Systems
  • 6.11.1. Surface plasma resonance (SPR) systems market estimates and forecasts 2018 to 2030 (USD Million)
• 6.12. Other Technologies
  • 6.12.1. Other technologies market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Proteomics Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory framework
    • 7.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.7. Norway
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Regulatory framework
    • 7.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Competitive scenario
    • 7.5.8.3. Regulatory framework
    • 7.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.9. Denmark
    • 7.5.9.1. Key country dynamics
    • 7.5.9.2. Competitive scenario
    • 7.5.9.3. Regulatory framework
    • 7.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework
    • 7.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory framework
    • 7.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory framework
    • 7.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Regulatory framework
    • 7.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Regulatory framework
    • 7.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Competitive scenario
    • 7.8.4.3. Regulatory framework
    • 7.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key country dynamics
    • 7.8.5.2. Competitive scenario
    • 7.8.5.3. Regulatory framework
    • 7.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2023
• 8.4. Company Profiles/Listing
  • 8.4.1. Illumina Inc.
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product/Service benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Agilent Technologies Inc.
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product/Service benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Bio-Rad Laboratories, Inc.
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product/Service benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Thermo Fisher Scientific, Inc.
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product/Service benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Bruker Corporation
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product/Service benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. F. Hoffmann-La Roche Ltd.
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product/Service benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Waters Corporation
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product/Service benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Merck KGaA
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product/Service benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Danaher
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product/Service benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Standard BioTools Inc.
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product/Service benchmarking
    • 8.4.10.4. Strategic initiatives